Illumina, Inc.
ILMN
Classificação em ações
#617
Illumina, Inc. specializes in delivering advanced genetic and genomic analysis... Illumina, Inc. specializes in delivering advanced genetic and genomic analysis tools, primarily through sequencing and array technologies. The company's offerings empower clients across various sectors to integrate genomic insights into both research and clinical environments, with applications spanning critical fields like life sciences, cancer diagnostics, reproductive health, agriculture, and innovative new domains. Illumina's portfolio encompasses specialized instrumentation and necessary consumables for genetic analysis, alongside comprehensive genotyping and sequencing services. They also offer instrument maintenance agreements, collaborate through development and licensing deals, and perform cancer detection tests. Its diverse clientele comprises leading genomic research facilities, universities, state-funded laboratories, medical centers, pharmaceutical and biotechnology firms, commercial molecular diagnostic providers, and businesses focused on consumer genomics. Illumina employs a two-pronged distribution strategy, selling directly to clients across North America, Europe, Latin America, and the Asia-Pacific. Additionally, it partners with life-science distributors to reach markets in Europe, the Asia-Pacific, Latin America, the Middle East, and Africa. Established in 1998, the company maintains its corporate headquarters in San Diego, California.
Preço da ação
$262.32
Última sincronização: 2026-10-16
Valor de mercado
$39.61B
Variação (1 dia)
-2.09%
Variação (1 ano)
174.80%
País
US
Negociar Illumina, Inc. (ILMN)
Categoria
Healthcare
EPS de Illumina, Inc. (ILMN)
EPS em June 2026 TTM: $5.41
De acordo com os últimos relatórios financeiros e o preço das ações da Illumina, Inc., o EPS atual da empresa (TTM) é $5.41. No final de 2024, a empresa teve um EPS de $-7.69, um aumento em relação a ao EPS de 2023, que foi de $-7.35.
Histórico de EPS da Illumina, Inc. de 2000 até 2026
EPS no final de cada ano
| Ano | EPS | Alterar |
|---|---|---|
| 2026 (TTM) | $5.41 | -1.10% |
| 2025 | $5.47 | -171.13% |
| 2024 | $-7.69 | 4.63% |
| 2023 | $-7.35 | -244.69% |
| 2022 | $5.08 | 13.90% |
| 2021 | $4.46 | -34.60% |
| 2019 | $6.82 | 21.35% |
| 2018 | $5.62 | 13.08% |
| 2017 | $4.97 | 57.78% |
| 2016 | $3.15 | -0.94% |
| 2015 | $3.18 | 21.84% |
| 2014 | $2.61 | 161.00% |
| 2013 | $1.00 | -18.70% |
| 2012 | $1.23 | 75.71% |
| 2011 | $0.70 | -30.69% |
| 2010 | $1.01 | 71.19% |
| 2009 | $0.59 | 37.21% |
| 2008 | $0.43 | -116.73% |
| 2007 | $-2.57 | -671.11% |
| 2006 | $0.45 | -273.08% |
| 2005 | $-0.26 | 199.54% |
| 2004 | $-0.09 | -79.33% |
| 2003 | $-0.42 | -35.38% |
| 2002 | $-0.65 | 54.76% |
| 2001 | $-0.42 | 27.27% |
| 2000 | $-0.33 | 0.00% |
EPS de empresas semelhantes ou concorrentes
| Empresa | EPS | Diferença de EPS | País |
|---|---|---|---|
| $18.62 | 244.18% |
US
|
|
| $5.65 | 4.44% |
US
|
|
| $-1.36 | -125.14% |
US
|
|
| - | - |
CN
|
|
| $5.09 | -5.91% |
US
|
